VCBeat Health Contact Us
Home Pfizer Plans to Submit Data for Fourth COVID-19 Vaccine Dose and Develops Variant-Proof Vaccine

Pfizer Plans to Submit Data for Fourth COVID-19 Vaccine Dose and Develops Variant-Proof Vaccine

Mar 14, 2022 10:09 CST Updated 10:09
FDA

U.S. Food and Drug Administration

Pfizer

Pharmaceutical R&D Developer

Recently, Pfizer CEO Albert Bourla announced that the company plans to submit data on the fourth dose of the COVID-19 vaccine to the U.S. FDA soon and is developing a vaccine that can prevent all variants of the coronavirus.

(Source: China Securities Network, "STAR Market Daily")

*Disclaimer: This article was written by an author who has settled in Sina Medicine News. The views expressed represent the personal opinions of the author and do not reflect the position of Sina Medicine News.